Treatment of Intermediate‐Risk Hepatoblastoma Using a Combined Cisplatin and Doxorubicin (PLADO) Regimen and Optimized Surgical Resection
The outcome for patients with intermediate-risk HB was satisfactory. PLADO, combined with surgery (including LTx) conducted at the optimal time, appeared to cure most patients in this study.
Authors
- Ken Hoshino (ORCID: https://orcid.org/0000-0002-3021-3029)
- Tomoro Hishiki (ORCID: https://orcid.org/0000-0002-2515-1054)
- Hiroki Nagase (ORCID: https://orcid.org/0000-0002-3992-5399)
- Kenichiro Watanabe (ORCID: https://orcid.org/0000-0002-8892-3082)
- Takeshi Inoue (ORCID: https://orcid.org/0000-0002-5251-2839)
- Eiso Hiyama (ORCID: https://orcid.org/0000-0001-9179-5037)
- Kohmei Ida
- Makiko Mori (ORCID: https://orcid.org/0000-0003-3427-2461)
- Yuichi Takama
- Masahiro Sekiguchi (ORCID: https://orcid.org/0000-0002-7941-9319)
- Yukichi Tanaka (ORCID: https://orcid.org/0000-0003-1145-5249)
- Kenichi Yoshimura (ORCID: https://orcid.org/0000-0001-7393-6932)
- Yohei Yamada (ORCID: https://orcid.org/0000-0001-6059-7660)
- Shohei Honda (ORCID: https://orcid.org/0000-0001-7927-1038)
- Osamu Miyazaki (ORCID: https://orcid.org/0000-0002-1793-4892)
- Yuki Nogami
- Akiko Yokoi (ORCID: https://orcid.org/0000-0003-4905-8011)
- Ryo Hanaki (ORCID: https://orcid.org/0000-0003-0010-112X)
- Motonari Nomura
- Tomoko Iehara
- Norihiko Kitagawa (ORCID: https://orcid.org/0000-0002-1629-5857)
- R Matsumura (ORCID: https://orcid.org/0000-0002-4871-928X)
- Takuro Kazama (ORCID: https://orcid.org/0000-0002-8950-5173)
- Hide Kaneda
- Junya Fujimura (ORCID: https://orcid.org/0000-0002-8542-013X)
- Tetsuya Takimoto (ORCID: https://orcid.org/0009-0009-3008-8078)
Institutions
- Nihon University (JP)
- Hiroshima University (JP)
- Chiba University (JP)
- Keio University (JP)
- Nagoya City University (JP)
- Juntendo University (JP)
- Kyoto Prefectural University of Medicine (JP)
- Tohoku University Hospital (JP)
- Saitama Children's Medical Center (JP)
- Osaka City General Hospital (JP)
- Kanagawa Children's Medical Center (JP)
- Mie University Hospital (JP)
- Hiroshima University Hospital (JP)
- Kobe Children's Hospital (JP)
- National Center For Child Health and Development (JP)
- Hokkaido University Hospital (JP)
- Tokyo National Hospital (JP)
- Shizuoka Children's Hospital (JP)
- Teikyo University (JP)
- The University of Osaka (JP)
Publication Details
- Journal
- Pediatric Blood & Cancer
- Published
- 2025-05-09
- DOI
- https://doi.org/10.1002/pbc.31770
- Citations
- 2
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 2.64
Funders
- Japan Agency for Medical Research and Development
- Japan Society for the Promotion of Science